Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

CAMMA', Calogero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.811
EU - Europa 8.753
AS - Asia 7.622
SA - Sud America 1.089
AF - Africa 232
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 11
Totale 36.531
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.556
SG - Singapore 2.882
RU - Federazione Russa 2.287
CN - Cina 1.948
IT - Italia 1.828
FI - Finlandia 1.103
BR - Brasile 873
HK - Hong Kong 788
DE - Germania 729
VN - Vietnam 641
UA - Ucraina 581
PL - Polonia 495
GB - Regno Unito 427
IE - Irlanda 363
FR - Francia 357
JP - Giappone 268
BD - Bangladesh 242
IN - India 197
KR - Corea 170
SE - Svezia 149
CA - Canada 126
TR - Turchia 111
RO - Romania 96
MX - Messico 81
NL - Olanda 79
AR - Argentina 73
CI - Costa d'Avorio 65
IQ - Iraq 62
AT - Austria 61
ZA - Sudafrica 49
PK - Pakistan 41
ES - Italia 40
BE - Belgio 39
SA - Arabia Saudita 36
EC - Ecuador 31
UZ - Uzbekistan 28
EG - Egitto 25
CO - Colombia 24
MY - Malesia 23
CL - Cile 21
JO - Giordania 20
PH - Filippine 20
VE - Venezuela 20
MA - Marocco 19
PY - Paraguay 19
KE - Kenya 18
TN - Tunisia 17
CZ - Repubblica Ceca 16
ID - Indonesia 16
IR - Iran 16
LT - Lituania 15
CH - Svizzera 14
DZ - Algeria 13
LB - Libano 12
AE - Emirati Arabi Uniti 11
BO - Bolivia 11
AU - Australia 10
AZ - Azerbaigian 10
NP - Nepal 10
AL - Albania 9
EU - Europa 9
GE - Georgia 9
TH - Thailandia 9
DK - Danimarca 8
GR - Grecia 8
PE - Perù 8
BY - Bielorussia 7
CR - Costa Rica 7
OM - Oman 7
BG - Bulgaria 6
DO - Repubblica Dominicana 6
IL - Israele 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
GY - Guiana 5
JM - Giamaica 5
KG - Kirghizistan 5
NG - Nigeria 5
NI - Nicaragua 5
NO - Norvegia 5
PA - Panama 5
SN - Senegal 5
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
ET - Etiopia 4
GT - Guatemala 4
HU - Ungheria 4
MD - Moldavia 4
MM - Myanmar 4
PS - Palestinian Territory 4
PT - Portogallo 4
RS - Serbia 4
UY - Uruguay 4
BN - Brunei Darussalam 3
HN - Honduras 3
KZ - Kazakistan 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
Totale 36.496
Salva come PNG Salva come JPEG
Città #
Fairfield 2.562
Ashburn 2.257
Singapore 2.038
Woodbridge 1.235
Chandler 1.100
Houston 978
Seattle 955
Wilmington 943
San Jose 861
Cambridge 825
Hong Kong 755
Ann Arbor 671
Palermo 497
Zgierz 425
Moscow 363
Dublin 362
Jacksonville 306
Medford 305
Beijing 286
Los Angeles 281
New York 269
Tokyo 253
Helsinki 241
Des Moines 238
Santa Clara 228
Altamura 226
Ho Chi Minh City 223
Council Bluffs 209
Frankfurt am Main 202
Lauterbourg 200
Nanjing 200
Princeton 189
Lawrence 174
Dallas 161
Hanoi 161
Boardman 140
San Diego 129
Hefei 123
The Dalles 102
Dearborn 91
Tulsa 86
Buffalo 84
London 80
Jinan 79
Milan 76
Shenyang 76
Chicago 72
Nanchang 66
São Paulo 66
Abidjan 65
Rome 62
Columbus 58
Orem 56
Phoenix 55
Tianjin 54
Hebei 53
Changsha 52
Warsaw 52
Izmir 51
Nuremberg 48
Jiaxing 47
Ludwigshafen am Rhein 47
Amsterdam 41
Brussels 38
Saint Petersburg 38
Zhengzhou 38
Ningbo 37
Montreal 35
Chennai 33
Atlanta 32
Guangzhou 32
Kumar 32
Brooklyn 31
Hangzhou 31
Seongnam 30
Bremen 29
Munich 29
Poplar 28
Verona 28
Venice 27
Da Nang 26
Mumbai 26
Paris 26
Denver 25
Falls Church 25
Haiphong 25
San Paolo di Civitate 25
Vienna 25
Johannesburg 24
Rio de Janeiro 24
Baghdad 23
Pune 22
Seoul 22
Manchester 21
Toronto 21
West Jordan 21
Taizhou 20
Biên Hòa 19
Mexico City 19
Shanghai 19
Totale 24.196
Salva come PNG Salva come JPEG
Nome #
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis 390
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease 334
A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. 328
Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C. 306
Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. 304
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease 297
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease 296
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension 293
The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease 293
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. 278
Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients 276
Survival of Patients with Hepatocellular Carcinoma (HCC) Treated by Percutaneous Radio-Frequency Ablation (RFA) Is Affected by Complete Radiological Response 274
Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease 269
Causes of and prevention strategies for hepatocellular carcinoma. 265
751 RETINOL-BINDING PROTEIN 4 (RBP4): A NEW MARKER OF G1 HCV-INDUCED STEATOSIS 262
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 262
Clinical implications of the hyperdynamic syndrome in cirrhosis. 255
Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women 255
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease 253
Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients With Chronic Hepatitis C Virus Genotype 1 Infection 248
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. 247
Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations. 246
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis 245
Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C 245
Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 245
Assessment of treatment response in hepatocellular carcinoma: a review of literature 238
MERTK rs4374383 polymorphism affects the severity of fibrosis in nonalcoholic fatty liver disease 238
Cost-Effectiveness of Boceprevir or Telaprevir for Untreated Patients with Genotype 1 Chronic Hepatitis C 235
Clinical trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites. 234
Treatment of hepatocellular carcinoma: present and future. 234
Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation 233
Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems 232
La termoablazione nel trattamento delle neoplasie epatiche primitive e secondarie 231
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 230
Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection. 229
Retinol-binding protein 4 (RBP4) : a new marker of G1 HCV-induced steatosis 227
Association of vitamin D serum levels and its common genetic determinants with severity of liver fibrosis in genotype 1 chronic hepatitis C patients 227
Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data 226
Inflammation and Aortic Stiffness: An Individual Participant Data Meta-Analysis in Patients With Inflammatory Bowel Disease. 226
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis 222
High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C 220
Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease 220
Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study 219
Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C 218
Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients 218
The impact of radiotherapy on survival in resectable gastric carcinoma: A meta-analysis of literature data. 216
Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis C virus genotype 1. 216
TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C 213
Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. 211
Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort 211
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 211
The ocular manifestations in IBD screening (OMIS) questionnaire: pilot study on detection of ocular involvement in inflammatory bowel diseases 210
The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease. 207
Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in post-operative Crohn's disease 204
Genetic predisposition to thrombophilia in inflammatory bowel disease 204
THE COMPLEX INTERPLAY BETWEEN VITAMIN D DEFICIENCY AND DIABETES 201
Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C 200
Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study 199
Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy 198
Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies 197
Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data 195
Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C 195
Transjugular Intrahepatic Portosystemic Shunt For Refractory Ascites: A Meta-Analysis Of Individual Patient Data 194
Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C 194
Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease 194
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 194
Risk Factors for Rate of Relapse and Effects of Steroid Maintenance Therapy in Patients With Autoimmune Pancreatitis: Systematic Review and Meta-analysis 194
Methylenetetrahydrofolate reductase homozygosis and low-density lipoproteins in patients with genotype 1 chronic hepatitis C 193
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents 193
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma 193
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? the REAL Experience 192
Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use 191
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 190
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease 190
Mortality in patients with hepatocellular carcinoma predicted by six scoring: none is the winner 189
Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis. 189
Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy. 189
Serum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases. 189
Radio-frequency thermal ablation (RFTA) of small hepatocellular carcinoma in patients with cirrhosis. Experience at a single tertiary referral center 189
Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. 189
PERCUTANEOUS RADIOFREQUENCY THERMAL ABLATION 8 RFTA) OF SMALL HEPATOCELLUALR CARCINOMA: A PROSPECTIVE STUDY 188
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values 188
Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib 188
Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma 188
Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients with Nonalcoholic Fatty Liver Disease 186
When and how to treat acute hepatitis C? 186
Treatment of hepatitis C: critical appraisal of the evidence 185
Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. 185
Peginterferon alfa-2b plus ribavirin for naive patients with genotype 1 chronic hepatitis C: a randomized controlled trial 184
Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy 184
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis 183
Cardiac involvement in patients with cirrhosis: a focus on clinical features and diagnosis 183
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 181
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C 181
Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years 181
Aminopyrine breath test predicts liver-related events and death in HCV-related cirrhosis on SVR after DAA therapy 180
Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma. 179
Insulin resistance is associated with steatosis in non-diabetic patients with genotype 1 chronic hepatitis C 179
Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis 177
The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity 176
Totale 22.119
Salva come PNG Salva come JPEG
Categoria #
all - tutte 127.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.963
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021291 0 0 0 0 0 0 0 0 0 0 0 291
2021/20222.423 178 522 62 68 66 98 137 142 297 249 189 415
2022/20233.136 338 663 44 352 306 484 176 211 382 17 110 53
2023/20241.197 52 205 67 88 89 300 115 59 22 31 28 141
2024/20253.597 76 186 296 348 114 163 229 207 280 430 474 794
2025/202613.596 851 393 738 1.087 1.231 2.151 1.839 1.563 1.059 1.800 765 119
Totale 37.503